Trial site
Tangshan People's Hospital
- 13running trials
- 2closed trials
The trials here
What the 15 trials at this site are about, from their registry records.
- Conditions
- Lung cancer4 trials
- Metastatic breast cancer3 trials
- Colorectal cancer2 trials
- Liver and biliary tract cancer2 trials
- Stroke2 trials
- Endometrial cancer1 trial
- Head and neck cancer1 trial
- Phase
- Phase 310 trials
- Phase 22 trials
- Phase 1/21 trial
- Status
- Active, not recruiting6 trials
- Not yet recruiting5 trials
- Recruiting2 trials
- Completed1 trial
- Terminated1 trial
- Lead sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.5 trials
- Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.2 trials
- Shanghai Henlius Biotech2 trials
- Akeso1 trial
- Bayer1 trial
- and 4 more
Running trials
Recruiting
TQB2930 Injection for the Treatment of HER2-positive Advanced Breast Cancer
Recruiting
Not yet recruiting
Inflammatory and Metabolic Prognostic Assessment in Critically Ill Neurological Patients
Recruiting
A Study of TQB2102 for Injection in the Treatment of HER2-positive Biliary Tract Cancer
Not yet recruiting
Anlotinib Hydrochloride Capsules Combined With TQB2450 in the Treatment of Endometrial Cancer
Recruiting
Recruiting
Active, not recruiting
A Clinical Study of TQB3454 Tablets in the Treatment of Advanced Biliary Carcinoma.
Active, not recruiting
Neoadjuvant Tislelizumab Plus Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer (NeoSPOT)
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer2 recruiting
- Metastatic breast cancer2 recruiting
- Endometrial cancer1 recruiting
- Liver and biliary tract cancer1 recruiting
- Stroke1 recruiting
Closed trials
Terminated
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026